PPARγ is involved in the hyperglycemia‐induced inflammatory responses and collagen degradation in human chondrocytes and diabetic mouse cartilages

Journal of Orthopaedic Research - Tập 33 Số 3 - Trang 373-381 - 2015
Ying‐Ju Chen1, Ding‐Cheng Chan2, Kuo‐Cheng Lan3, Shyh‐Jye Chen4, Chang−Mu Chen5, S.-H. Chao3, Keh‐Sung Tsai6, Rong‐Sen Yang7, Shing‐Hwa Liu8,4,1
1Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan
2Department of Geriatrics and Gerontology, National Taiwan University Hospital, Taipei, Taiwan
3Department of Emergency Medicine, National Defense Medical Center, Tri-Service General Hospital, Taipei, Taiwan
4Department of Pediatrics, College of Medicine, National Taiwan University, Taipei, Taiwan
5Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan
6Department of Laboratory Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan
7Department of Orthopaedics, College of Medicine, National Taiwan University, Taipei, Taiwan
8Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan

Tóm tắt

ABSTRACTDiabetic hyperglycemia has been suggested to play a role in osteoarthritis. Peroxisome proliferator‐activated receptor‐γ (PPARγ) was implicated in several pathological conditions including diabetes and inflammation. The detailed effects and mechanisms of hyperglycemia on cartilage damage still need to be clarified. Here, we investigated the role of PPARγ in hyperglycemia‐triggered chondrocyte/cartilage damages using a human chondrocyte culture model and a diabetic mouse model. Human chondrocytes were cultured and treated with high concentration of glucose (30 mM) to mimic hyperglycemia in the presence or absence of pioglitazone, a PPARγ agonist. Streptozotocin (STZ) was used to induce mouse diabetes. Our data showed that high glucose induced the protein expressions of cyclooxygenase‐2 (COX‐2) and production of prostaglandin‐E2 (PGE2), interleukin‐6 (IL‐6), and metalloproteinase‐13 (MMP‐13), but decreased the protein expression of collagen II and PPARγ in human chondrocytes. These alterations in high glucose‐treated human chondrocytes could be reversed by pioglitazone in a dose‐dependent manner. Moreover, pioglitazone administration could also significantly reverse the hyperglycemia, formation of AGEs, productions of IL‐6 and MMP‐13, and cartilage damage in STZ‐induced diabetic mice. Taken together, these findings suggest that hyperglycemia down‐regulates PPARγ expression and induces inflammatory and catabolic responses in human chondrocytes and diabetic mouse cartilages. © 2014 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 33:???–???, 2015.

Từ khóa


Tài liệu tham khảo

10.1016/j.biochi.2009.10.006

10.1124/mol.107.036541

10.1002/jcp.21258

10.1016/j.bmc.2007.01.011

10.1101/gad.815400

10.1016/j.ejphar.2013.12.035

10.1146/annurev.biochem.77.032207.120833

10.1016/j.bbapap.2011.06.020

10.1016/j.jbspin.2013.09.007

Hart DJ, 1995, Association between metabolic factors and knee osteoarthritis in women: The Chingford Study, J Rheumatol, 22, 1118

10.2174/1573399810602040455

Waine H, 1961, Association of osteoarthritis and diabetes mellitus, Tufts Folia Med, 7, 13

10.2337/dc12-0924

10.1097/RHU.0b013e31827cd578

10.1007/s00590-011-0915-6

10.1007/s11999-013-3026-3

10.1016/j.berh.2006.06.003

10.1152/ajpregu.1999.276.4.R1164

10.1002/jcb.23196

Gillery P, 2006, Oxidative stress and protein glycation in diabetes mellitus, Ann Biol Clin (Paris), 64, 309

10.1155/2013/403460

10.1016/j.bbamcr.2012.08.021

10.1093/rheumatology/kem376

10.1371/journal.pone.0066611

10.1002/art.21523

Atayde SA, 2012, Experimental diabetes modulates collagen remodelling of joints in rats, Histol Histopathol, 27, 1471

10.1210/endo.137.1.8536636

10.1016/0092-8674(94)90006-X

10.1210/endo.135.2.8033830

10.1155/2008/679137

10.3109/s10165-010-0347-x

Von Knethen A, 2003, PPARγ–an important regulator of monocyte/macrophage function, Arch Immunol Ther Exp (Warsz), 51, 219

10.4049/jimmunol.170.5.2663

10.1002/1529-0131(200103)44:3<595::AID-ANR108>3.0.CO;2-8

10.1002/art.20792

10.1053/joca.2001.0485

10.2106/00004623-197153030-00009

10.1097/BOR.0b013e32831bc0c4

10.1016/S0140-6736(05)67029-8

10.1177/039463201002300404

10.1172/JCI119316

10.1136/ard.2010.146399

10.1002/art.21254

10.1161/01.CIR.0000034509.14906.AE

10.1016/j.joca.2010.08.016

10.1038/34184

10.1016/j.ajpath.2012.12.012

Monemdjou R, Association of cartilage‐specific deletion of peroxisome proliferator‐activated receptor‐γ with abnormal endochondral ossification and impaired cartilage growth and development in a murine model, Arthritis Rheum, 64, 1551, 10.1002/art.33490

10.1002/art.22726

10.1002/art.20792